Target intelligence / Profile preview

Flavivirus envelope protein (E protein) (E protein)

Target
E protein
Molecular classification
Viral surface protein, Class II fusion protein, Glycoprotein
01

Overview

The Flavivirus envelope protein (E protein) is the primary structural component on the surface of flaviviruses, including Dengue, Zika, and West Nile viruses (PMID: 35412141). It is a class II fusion protein that mediates both the initial attachment of the virus to host cell receptors and the subsequent fusion of the viral and endosomal membranes (PMID: 18602144). On the mature virion, the E protein exists as 90 head-to-tail homodimers arranged in a herringbone pattern (PMC5894644). Upon exposure to the acidic environment of the endosome, the protein undergoes a dramatic conformational change, transitioning from a dimer to a fusogenic trimer that inserts its fusion loop into the host membrane (PMID: 22231303). This process is a critical step in the viral life cycle and is the primary target for neutralizing antibodies and experimental entry inhibitors (PMID: 35412141). Small molecules and peptides targeting the E protein aim to either block receptor binding or stabilize the prefusion dimer to prevent membrane fusion (PMC5894644). However, the high genetic diversity of flaviviruses and the risk of antibody-dependent enhancement (ADE) present significant challenges for therapeutic development (PMID: 18602144).

Other names
Envelope proteinE glycoproteinFlavivirus E proteinViral envelope protein
02

Mechanism of action

Inhibition of viral attachment to host receptors and prevention of pH-dependent membrane fusion by stabilizing the prefusion dimer or blocking the fusion loop.

03

Biological functions

Viral attachmentMembrane fusionReceptor bindingEndocytosis mediator
04

Disease associations

InfectionDengue feverZika virus infectionWest Nile feverYellow feverJapanese encephalitis
05

Safety considerations

Antibody-dependent enhancement (ADE)Viral resistance due to E protein mutationsStructural diversity across flavivirus species
06

Interacting drugs

Cyanohydrazones (e.g., 3-110-22)

6 more in the full profile.

07

Biomarkers

Viral RNA (RT-PCR)NS1 antigenNeutralizing antibody titer

Beyond the preview

Go deeper on Flavivirus envelope protein (E protein) (E protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavivirus envelope protein (E protein) (E protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call